liverRegression code.

liverRegression code.

<p dir="ltr">Enhancers are transcriptional regulatory elements that help drive phenotypic diversity, yet they often undergo rapid sequence evolution despite functional conservation, posing a challenge for predicting their function across species. Previous machine learning models have...

Szczegółowa specyfikacja

Zapisane w:

Opis bibliograficzny
1. autor:	Amy Stephen (22684448) (author)
Wydane:	2025
Hasła przedmiotowe:	Bioinformatic methods development Genomics and transcriptomics Convolutional Neural Networks. comparative genomics approaches
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

DeepEvo
od: Juntian Qi (22578974)
Wydane: (2025)

Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Wydane: (2025)

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Wydane: (2025)

Supplementary Figure 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Wydane: (2025)

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Wydane: (2025)

Supplementary Table 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Wydane: (2025)

Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Wydane: (2025)

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Wydane: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Wydane: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Wydane: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Wydane: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Wydane: (2025)

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Wydane: (2025)

<b>Minimal repeats identified by machine learning as novel cross-species markers of translation initiation sites</b>
od: Ali Mohammad Ali Maddi (11301486)
Wydane: (2025)

Supplementary File 1 from Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer
od: Rania Bassiouni (14963190)
Wydane: (2025)

Supplementary File 2 from Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer
od: Rania Bassiouni (14963190)
Wydane: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Wydane: (2025)

Table S2 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
od: Elena Llano (14963220)
Wydane: (2025)

Table S3 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
od: Elena Llano (14963220)
Wydane: (2025)

Table S5 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
od: Elena Llano (14963220)
Wydane: (2025)

table s1 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
od: Elena Llano (14963220)
Wydane: (2025)

table s4 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
od: Elena Llano (14963220)
Wydane: (2025)

Data Sheet 1_Genome-wide identification and expression profiling of bHLH transcription factors associated with ferulic acid biosynthesis in Angelica sinensis.zip
od: Khadija Tehseen Arshad (22687526)
Wydane: (2025)

Table 1_Genome-wide identification and expression profiling of bHLH transcription factors associated with ferulic acid biosynthesis in Angelica sinensis.xlsx
od: Khadija Tehseen Arshad (22687526)
Wydane: (2025)

scRNA-seq, Oligodendrocyte-Lineage Meta-Atlas
od: Nicholas Mikolajewicz (11242755)
Wydane: (2025)

基于机器学习和网络药理学分析类风湿关节炎中大麻二酚治疗双靶点机制
od: xiaohua fang (22678832)
Wydane: (2025)

Structural variants of <i>Fragaria vesca</i>
od: Minto Odagiri (22680003)
Wydane: (2025)

Gene expression data of <i>Fragaria vesca</i>
od: Minto Odagiri (22680003)
Wydane: (2025)

Supplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
od: Dhruv Chachad (14954640)
Wydane: (2025)

Cannot write session to /tmp/vufind_sessions/sess_n4au7hbgrmjq0b19ru5ekg5a8f